摘要
采用国产安吖啶（ｍ－ａｍｓａｃｒｉｎｅ，ＡＭＳＡ）联合方案治疗急性白血病（ＡＬ）３０例；急性淋巴细胞白血病（ＡＬＬ）６例，急性非淋巴细胞白血病（ＡＮＬＬ）２４例；初治２１例，复治９例。总的ＣＲ率为７６．７％；ＡＬＬ的ＣＲ率为６６．６％，ＡＮＬＬ的ＣＲ率为７９．２％，初、复治病例的ＣＲ率分别为８０．９％、６６．７％。主要毒性为骨髓抑制，其次为脱发、食欲下降、恶心、呕吐、口腔粘膜炎、静脉炎等。
Patients with acute leukemias, 6 acute lymphoblastic leukemias(ALL) and 24 acute nonlymphoblastic leukemias(ANLL), were treated with combination chemotherapy including domestic Amascrine(m AMSA). The total CR rates was 76.7%(66.6% in ALL, 79.2% in ANLL). The CR rates of previously untreated and treated patients were 80.9% and 66.7%, respectively. The chief toxicity was myelosuppression, aloecia, nausea, vomiting, mucositis and phlebitis.
出处
《白血病》
1997年第2期68-70,共3页
